{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:06:57Z","timestamp":1790194017777,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaccas.2026.110351","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:50:27Z","timestamp":1790193027000},"page":"110351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coexistence of Hypertrophic Cardiomyopathy and Hereditary Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.1016","volume":"31","author":[{"given":"Roxanne","family":"Coderre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Tersalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalyn O.","family":"Adigun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Boilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Borgeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo L.","family":"Clavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar F.","family":"AbouEzzeddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaccas.2026.110351_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cardfail.2023.10.279","article-title":"Left ventricular outflow tract obstruction in cardiac amyloidosis","volume":"30","author":"Longinow","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.jaccas.2026.110351_bib2","article-title":"Cardiac amyloidosis presenting with dynamic left ventricular outflow tract obstruction resembling hypertrophic obstructive cardiomyopathy","volume":"10","author":"Sattar","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.jaccas.2026.110351_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5334\/gh.1262","article-title":"World Heart Federation consensus on transthyretin amyloid cardiomyopathy (ATTR-CM)","volume":"18","author":"Brito","year":"2023","journal-title":"Glob Heart"},{"issue":"37","key":"10.1016\/j.jaccas.2026.110351_bib4","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccas.2026.110351_bib5","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.jaccas.2026.110351_bib6","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2021.03.008","article-title":"Myocardial histopathology in patients with obstructive hypertrophic cardiomyopathy","volume":"77","author":"Cui","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccas.2026.110351_bib7","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.amjcard.2014.07.058","article-title":"Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopathy undergoing septal myectomy for left ventricular outflow tract obstruction","volume":"114","author":"Helder","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jaccas.2026.110351_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2025.107779","article-title":"Prevalence of amyloid deposition in patients undergoing septal myectomy for presumed hypertrophic cardiomyopathy","volume":"80","author":"Katzianer","year":"2026","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jaccas.2026.110351_bib9","article-title":"Variant cardiac transthyretin amyloidosis presenting as hypertrophic cardiomyopathy with left ventricular outflow tract obstruction","volume":"9","author":"H\u00f6ller","year":"2025","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.jaccas.2026.110351_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926035126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926035126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:51:15Z","timestamp":1790193075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084926035126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666084926035126"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.110351","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coexistence of Hypertrophic Cardiomyopathy and Hereditary Transthyretin Amyloid Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.110351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"110351"}}